全文获取类型
收费全文 | 438篇 |
免费 | 23篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 16篇 |
妇产科学 | 11篇 |
基础医学 | 34篇 |
口腔科学 | 48篇 |
临床医学 | 38篇 |
内科学 | 119篇 |
皮肤病学 | 12篇 |
神经病学 | 22篇 |
特种医学 | 2篇 |
外科学 | 58篇 |
综合类 | 6篇 |
一般理论 | 1篇 |
预防医学 | 43篇 |
眼科学 | 7篇 |
药学 | 24篇 |
肿瘤学 | 18篇 |
出版年
2023年 | 12篇 |
2022年 | 12篇 |
2021年 | 20篇 |
2020年 | 17篇 |
2019年 | 15篇 |
2018年 | 22篇 |
2017年 | 13篇 |
2016年 | 24篇 |
2015年 | 16篇 |
2014年 | 26篇 |
2013年 | 37篇 |
2012年 | 54篇 |
2011年 | 49篇 |
2010年 | 10篇 |
2009年 | 15篇 |
2008年 | 22篇 |
2007年 | 22篇 |
2006年 | 20篇 |
2005年 | 19篇 |
2004年 | 13篇 |
2003年 | 11篇 |
2002年 | 7篇 |
2001年 | 2篇 |
1999年 | 2篇 |
1994年 | 1篇 |
1989年 | 1篇 |
排序方式: 共有462条查询结果,搜索用时 15 毫秒
31.
Women who refrain from undergoing breast cancer screening are believed to be uninformed about risks and usually labeled as irrational. Our purpose in writing this paper is to challenge the traditional notion of rational behaviour, illustrating with qualitative data that people's rationality is influenced by their socio-cultural and political identities. We explore three major themes: (1) cultural explanations regarding intention to use screening mammography (2) (dis)trust in science and expert opinion, and (3) self-responsibility and self-surveillance in caring for one's body. Understanding that women rely on different risk discourses to make decisions about their health should aide researchers, health professionals, and the community in better understanding alternative ways of conceptualizing people's health-related behaviours when they do not coincide with health authorities recommendations. 相似文献
32.
33.
A. Montazeri Iraj Harirchi Mariam Vahdani Fatemeh Khaleghi Soghra Jarvandi Mandana Ebrahimi Mehregan Haji-Mahmoodi 《Supportive care in cancer》1999,7(6):400-406
The objective of this study was to test the reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30). The English-language version of the questionnaire was translated into Persian (Iranian language), and its final form was approved by the EORTC Study Group on Quality of Life before it was used in this study. The questionnaire was administered at two time points to a consecutive sample of 168 newly diagnosed breast cancer patients, and almost all of them (99%) found the questions easy to understand and acceptable. Crohnbach's alpha coefficient for multi-item scales (to test reliability) ranged from 0.48 to 0.95 at baseline and from 0.52 to 0.98 at follow-up administration of the questionnaire. Validity was checked using two methods: inter-scale correlation and known-groups comparison. Almost all inter-scale correlations were statistically significant in the expected direction. Known-groups comparison analysis showed that all functioning and symptom scales discriminated between subgroups of patients differing in clinical status as defined by their performance status and disease stage. In general, the findings of this study indicate that the Iranian version of the EORTC QLQ-C30 is a reliable and valid measure of quality of life in cancer patients and can be used in clinical trials and studies of outcome research in oncology. 相似文献
34.
Mandana Rafeey Reza Ghotaslou Solmaz Nikvash Asghar Ashrafy Hafez 《Journal of infection and chemotherapy》2007,13(5):291-295
Helicobacter pylori-associated infection is extre-mely common in Iran, as in other developing countries, but few data exist on the susceptibility
of H. pylori to antimicrobials commonly used in the eradication schedules in this country. This study was performed to determine the resistance
rate to six antimicrobial agents used in the treatment of H. pylori infection in dyspeptic Iranian children and to recommend an updated anti-H. pylori treatment regimen to use in children. All H. pylori isolated from children who were undergoing gastroscopy were prospectively collected and subcultured to yield their susceptibility
to six antimicrobial agents, by E test and disk diffusion methods. Demographic data and presenting symptoms were also collected.
A prospective study was carried out from January 2003 to January 2005 with 100 strains of H. pylori isolated from children (40 girls and 60 boys; age range, 1.5 to 16 years [mean, 9.22 ± 3.25 years]); the strains had been
successfully subcultured to yield antimicrobial sensitivity. Overall the H. pylori resistance rate was 95% to metronidazole, 59% to amoxicillin, 16% to clarithromycin, 9% to furazolidone, 7% to ciprofloxacin,
and 5% to tetracycline. The most common presenting symptom was abdominal pain. There were no statistically significant differences
in antimicrobial resistance rates related to age, sex, or clinical presentation. In the Iranian children, the prevalence of
H. pylori resistance was very high to metronidazole and amoxicillin, moderate to clarithromycin, and low to ciprofloxacin and tetracycline. 相似文献
35.
Mandana ARSHI John CARDINAL Rebecca J. HILL Peter S.W. DAVIES Claire WAINWRIGHT 《Respirology (Carlton, Vic.)》2010,15(5):779-784
Background and objective: Increased BMI is a risk factor for asthma in children and may be related to adipokines. Adipokines affect insulin‐stimulated glucose uptake in vitro but, to date there is little evidence for such a role in vivo. We explored relationships between obesity and allergic asthma in children. Methods: Twenty‐one allergic asthmatics (AA) and 10 non‐allergic healthy controls, aged 6–17.9 years were studied. AA group included children with a positive mannitol challenge test, >25 ppb of exhaled nitric oxide and a positive skin prick test. BMI z‐scores were calculated. Blood levels of insulin, glucose, leptin, resistin, tumour necrosis factor‐α, IL‐4, IL‐5 and IL‐6 were measured. Insulin resistance (IR) was estimated using the homeostasis model assessment (HOMA). Results: There was no significant difference in BMI z‐scores between AA and healthy controls (mean: 0.01 vs ?0.10). However, significant differences were found in the blood levels of IL‐6 (P = 0.05), IL‐4 (P = 0.04), IL‐5 (P = 0.01) and leptin (P = 0.02). IR was only found in the AA group (42.85%). Homeostasis model assessment insulin resistance (HOMA‐IR) was significantly related to IL‐6 (r = 0.44, P = 0.05) and tumour necrosis factor‐α (r = ?0.45, P = 0.05). Conclusions: IR was observed in AA. Our findings are suggestive of a complex interaction between the inflammatory state and adiposity, allergy and asthma. 相似文献
36.
37.
38.
39.
Sitruk-Ware RL Menard J Rad M Burggraaf J de Kam ML Tokay BA Sivin I Kluft C 《Contraception》2007,75(6):430-437
OBJECTIVE: We evaluated the effects of a new combined hormonal contraceptive vaginal ring (CVR) delivering the nonandrogenic progestin Nestorone (NES) and ethinyl estradiol (EE) on several key estrogen-sensitive hepatic proteins that may be markers for the risk of arterial or venous disease events and on blood pressure (BP). Because the pharmacologic androgenicity of the progestin in these formulations influences the hepatic impact of EE, we selected an oral contraceptive (OC) delivering the androgenic progestin levonorgestrel (LNG) and EE as the comparator. We also investigated the effect of delivery route, which is known to modify the hepatic effects of estradiol, but has not been widely studied with EE. STUDY METHODS: Women, aged 18-34 years, with no contraindications to the use of combined OCs, were randomized to three cycles of treatment with a CVR delivering NES/EE (150/15 microg/day) or a combined OC providing LNG and EE (150/30 microg per tablet). Each cycle consisted of 21 days of active treatment, followed by 7 days without treatment. During the last weeks of the pretreatment and third treatment cycles, blood samples were obtained for determinations of plasma concentrations of angiotensinogen, an estrogen-sensitive hepatic protein, and serum concentrations of sex hormone-binding globulin (SHBG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG) and estrogen- and androgen-sensitive proteins. BP was also measured. RESULTS: Of 47 women randomized, 45 completed the study (CVR: 23; OC: 22). Within-group comparisons over time by repeated-measure analysis of variance demonstrated statistically significant changes over time with both treatments for all hepatic proteins (p < .02) but not for TC. The within-group effects, presented as relative percent difference [95% confidence interval (CI)], were greatest for angiotensinogen [CVR: 227% (195-262%); OC: 251.3% (218-288%)] and SHBG [CVR: 306% (237-389%); OC: 55% (30-86)]. Both treatments were associated with small changes in systolic BP and diastolic BP (DBP), but only the within-group change in DBP for the OC group was statistically significant (p = .04). Between-treatment comparisons of third treatment cycle mean values were performed by analysis of covariance (baseline values as covariate). No statistically significant between-treatment differences were found for angiotensinogen, sensitive only to estrogen, or BP. Statistically significant treatment differences were found for all estrogen- and androgen-sensitive proteins (p < or = .002) but not for TC. When presented as relative percent difference between the effects of treatment (CVR-OC/OC; 95% CI of percent difference), the difference was largest for SHBG (159% [117-210%]); smaller relative percent differences were found for HDL-C [31.9% (18.5-46.8%)], LDL-C [23.6% (33.4% to -2.4%)] and TG [39.0% (14.0-69.4%)], but not TC. CONCLUSION: Vaginal delivery of a combined hormonal contraceptive did not reduce the EE-associated changes in estrogen-sensitive hepatic proteins observed after use of a combined OC. Significant treatment differences between the NES/EE CVR and the LNG/EE OC were found for SHBG, HDL-C, LDL-C, and TG, proteins sensitive to androgen as well as estrogen. No treatment difference was observed for angiotensinogen, which is sensitive only to estrogen. The observed treatment differences were therefore most likely due to the difference in androgenicity between NES and LNG. 相似文献
40.